Cancer Research Cell Death Mechanisms and Cancer Therapy  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Published online first on January 27, 2009
[Cancer Research, 10.1158/0008-5472.CAN-08-1189]
This Article
Right arrow Full Text (Online First [PDF])
Right arrow Supplementary Data
Right arrow All Versions of this Article:
0008-5472.CAN-08-1189v1
69/3/741    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hong, S.-W.
Right arrow Articles by Lee, M.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hong, S.-W.
Right arrow Articles by Lee, M.-S.

Priority Reports

p34SEI-1 Inhibits Apoptosis through the Stabilization of the X-Linked Inhibitor of Apoptosis Protein: p34SEI-1 as a Novel Target for Anti–Breast Cancer Strategies

Seung-Woo Hong 1, 2, 7, Chang-Jae Kim 3, Won-Sang Park 3, Jae-Sik Shin 1, 2, Soon-Duck Lee 1, Seong-Gyu Ko 6, Sam-Il Jung 1, In-Chul Park 4, Sung-Kwan An 5, Won-Keun Lee 7, Wang-Jae Lee 2, Dong-Hoon Jin 1, 2*, Myeong-Sok Lee 1

1Research Center for Women's Diseases, Division of Biological Sciences, Sookmyung Women's University, 2Department of Anatomy and Tumor Immunity Medical Research Center, Seoul National University College of Medicine, 3Department of Pathology, Catholic of University College of Medicine, 4Division of radiation cancer biology, Korea institute of Radiological and Medical Sciences, 215-4 Gongneung-dong, Nowon-ku, 139-706, 5Department of Microbial Engineering, Konkuk University, and 6Department of Basic Science of Oriental Medicine, Laboratory of Clinical Biology and Pharmacogenomics Institute of Oriental Medicine, Kyunghee University, Seoul, Korea; and 7Department of Biological Sciences, Myongji University, San38-2 Namdong, cheoin-gu, Youngin, Gyeonggido, Korea

* To whom correspondence should be addressed. E-mail: inno183{at}sm.ac.kr.


   Abstract

The p34SEI-1 protein exerts oncogenic effects via regulation of the cell cycle, which occurs through a direct interaction with cyclin-dependent kinase 4. Such regulation can increase the survival of various types of tumor cells. Here, we show that the antiapoptotic function of p34SEI-1 increases tumor cell survival by protecting the X-linked inhibitor of apoptosis protein (XIAP) from degradation. Our findings show that p34SEI-1 inhibits apoptosis. This antiapoptotic effect was eliminated by the suppression of p34SEI-1 expression. We also determined that direct binding of p34SEI-1 to the BIR2 domain prevents ubiquitination of XIAP. Interestingly, p34SEI-1 expression is absent or weak in normal tissues but is strongly expressed in tissues obtained from patients with breast cancer. Furthermore, the expression levels of p34SEI-1 and XIAP seem to be coordinated in human breast cancer cell lines and tumor tissues. Thus, our findings reveal that p34SEI-1 uses a novel apoptosis-inhibiting mechanism to stabilize XIAP. [Cancer Res 2009;69(3):741–6]

Key Words: P34SEI-1, XIAP, apoptosis, ubiquitination







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2009 by the American Association for Cancer Research.